The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.
Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results